Macobs Technologies’s IPO will hit the market on July 16, 2024, and closes on July 19, 2024. The Macobs Technologies IPO GMP Kostak rate and subject to sauda updated as of today. The Macobs Technologies IPO Grey Market Premium has started with low premium rates at this time, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check the Macobs Technologies IPO subscription status here.
Macobs Technologies Limited was founded in 2019 and offers products for male grooming. The company offers specialized trimmers for sensitive areas, hygiene products tailored to male skin, briefs, and a variety of self-care items via its own website. The company does not have physical stores or a traditional retail presence.
Macobs Technologies IPO Issue size of ₹19.46 Crores, in which Fresh Issue of ₹19.46 Crores and issue price band has been fixed at ₹71 to ₹75 Per Share. The Macobs Technologies IPO is to be listed on July 24, 2024, NSE, SME. You can check Macobs Technologies IPO Allotment Status here.
What is Macobs Technologies IPO GMP Today?
■ The Macobs Technologies IPO GMP Today Or Grey Market Premium is ₹17.
What is Macobs Technologies IPO Kostak Rates Today?
■ The Macobs Technologies IPO Kostak rate is ₹0.
What is Macobs Technologies IPO Subject to Sauda Price Today?
■ The Macobs Technologies IPO Subject to Sauda rates is ₹20500.
Macobs Technologies IPO Approximately Returns?
■ The Macobs Technologies IPO’s approximate return is 25%, which can also change according to the Market Sentiment.
Macobs Technologies IPO GMP Live, Kostak, & Subject :
Date | GMP | Kostak | Subject |
24 Jul 2024 | List:₹96 Gain:28.00% | ₹0 | ₹20500 |
23 Jul 2024 | ₹17 | ₹0 | ₹20500 |
22 Jul 2024 | ₹17 | ₹0 | ₹20500 |
21 Jul 2024 | ₹25 | ₹0 | ₹30500 |
20 Jul 2024 | ₹25 | ₹0 | ₹30500 |
19 Jul 2024 | ₹25 | ₹0 | ₹30500 |
18 Jul 2024 | ₹20 | ₹0 | ₹24500 |
17 Jul 2024 | ₹11 | ₹0 | ₹13500 |
16 Jul 2024 | ₹15 | ₹0 | ₹18500 |
15 Jul 2024 | ₹11 | ₹0 | ₹13500 |
14 Jul 2024 | ₹11 | ₹0 | ₹13500 |
13 Jul 2024 | ₹11 | ₹0 | ₹13500 |
12 Jul 2024 | ₹11 | ₹0 | ₹13500 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your own research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on several factors, including the overall market sentiment and the company’s performance in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the general stock market volatility.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even decline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
Macobs Technologies IPO Details: Click Here Macobs Technologies IPO Subscription: Click Here Macobs Technologies IPO Allotment: Click Here Macobs Technologies IPO Listing: Click Here |
All Macobs Technologies IPO-related links are available here. If you want to know the details, click here.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.